Indaptus Therapeutics Inc is trading 8.1% down at $4.14 as the stock undergoes a period of consolidation following a significant multi-day rally.
- The stock recently experienced a sharp surge, jumping from $2.02 on June 9 to a peak of $4.50 on June 17.
- The current pullback appears to be driven by momentum and profit-taking rather than any new company-specific developments.